PET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS and IPF

NCT06683612 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Multiple Sclerosis
Multiple Sclerosis, MS
Multiple Sclerosis, Primary Progressive
Multiple Sclerosis, Progressive
Multiple Sclerosis, Secondary Progressive
Healthy
Healthy Volunteers

Interventions

DRUG: PIPE-791

Sponsor

Contineum Therapeutics